TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
| Total assets (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $113.2B | +11.8% | 9.8% | 10.5% |
| Total assets (Q2 2026) | $113.2B |
|---|---|
| YoY | +11.8% |
| 5-year CAGR | 9.8% |
| 10-year CAGR | 10.5% |
Total assets
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $110.3B | +13.4% |
| 2024 | $97.3B | −1.4% |
| 2023 | $98.7B | +1.6% |
| 2022 | $97.2B | +2.1% |
| 2021 | $95.1B | +37.8% |
| 2020 | $69.1B | +18.3% |
| 2019 | $58.4B | +3.8% |
| 2018 | $56.2B | −0.8% |
| 2017 | $56.7B | +23.4% |
| 2016 | $45.9B | +12.4% |
| 2015 | $40.8B | −4.7% |
| 2014 | $42.9B | +34.5% |
| 2013 | $31.9B | +16.1% |
| 2012 | $27.4B | +2.3% |
| 2011 | $26.8B | +25.7% |
| 2010 | $21.3B | −1.3% |
| 2009 | $21.6B | +2.5% |
| 2008 | $21.1B | — |